Kimmelman J - Search Results

1

Probability of Success and Timelines for the Development of Vaccines for Emerging and Reemerged Viral Infectious Diseases.

MacPherson A, Hutchinson N, Schneider O, Oliviero E, Feldhake E, Ouimet C, Sheng J, Awan F, Wang C, Papenburg J, Basta NE, Kimmelman J. MacPherson A, et al. Among authors: kimmelman j. Ann Intern Med. 2021 Mar;174(3):326-334. doi: 10.7326/M20-5350. Epub 2020 Nov 24. Ann Intern Med. 2021. PMID: 33226855 Free PMC article.

2

Accelerated Drug Approval and Health Inequality.

London AJ, Kimmelman J. London AJ, et al. Among authors: kimmelman j. JAMA Intern Med. 2016 Jul 1;176(7):883-4. doi: 10.1001/jamainternmed.2016.2534. JAMA Intern Med. 2016. PMID: 27295005 No abstract available.

3

Nonpublication of trial results for new neurological drugs: A systematic review.

Hakala AK, Fergusson D, Kimmelman J. Hakala AK, et al. Among authors: kimmelman j. Ann Neurol. 2017 Jun;81(6):782-789. doi: 10.1002/ana.24952. Epub 2017 Jun 5. Ann Neurol. 2017. PMID: 28486773 Review.

4

Evaluation of Journal Registration Policies and Prospective Registration of Randomized Clinical Trials of Nonregulated Health Care Interventions.

Azar M, Riehm KE, Saadat N, Sanchez T, Chiovitti M, Qi L, Rice DB, Levis B, Fedoruk C, Levis AW, Kloda LA, Kimmelman J, Benedetti A, Thombs BD. Azar M, et al. Among authors: kimmelman j. JAMA Intern Med. 2019 May 1;179(5):624-632. doi: 10.1001/jamainternmed.2018.8009. JAMA Intern Med. 2019. PMID: 30855655 Free PMC article.

5

Ethical development of stem-cell-based interventions.

MacPherson A, Kimmelman J. MacPherson A, et al. Among authors: kimmelman j. Nat Med. 2019 Jul;25(7):1037-1044. doi: 10.1038/s41591-019-0511-6. Epub 2019 Jul 3. Nat Med. 2019. PMID: 31270501 Review.

6

Risks and benefits of unapproved disease-modifying treatments for neurodegenerative disease.

Feustel AC, MacPherson A, Fergusson DA, Kieburtz K, Kimmelman J. Feustel AC, et al. Among authors: kimmelman j. Neurology. 2020 Jan 7;94(1):e1-e14. doi: 10.1212/WNL.0000000000008699. Epub 2019 Dec 2. Neurology. 2020. PMID: 31792092 Free PMC article.

7

Ethical and Policy Issues for Seamless Phase I Oncology Trials.

Hutchinson N, Vinarov E, Iasonos A, Kimmelman J. Hutchinson N, et al. Among authors: kimmelman j. J Clin Oncol. 2020 Mar 1;38(7):669-673. doi: 10.1200/JCO.19.02456. Epub 2019 Dec 26. J Clin Oncol. 2020. PMID: 31877086 No abstract available.

8

Patient burden and clinical advances associated with postapproval monotherapy cancer drug trials: a retrospective cohort study.

Carlisle BG, Doussau A, Kimmelman J. Carlisle BG, et al. Among authors: kimmelman j. BMJ Open. 2020 Feb 17;10(2):e034306. doi: 10.1136/bmjopen-2019-034306. BMJ Open. 2020. PMID: 32071183 Free PMC article.

9

Wisdom of the expert crowd prediction of response for 3 neurology randomized trials.

Atanasov P, Diamantaras A, MacPherson A, Vinarov E, Benjamin DM, Shrier I, Paul F, Dirnagl U, Kimmelman J. Atanasov P, et al. Among authors: kimmelman j. Neurology. 2020 Aug 4;95(5):e488-e498. doi: 10.1212/WNL.0000000000009819. Epub 2020 Jun 16. Neurology. 2020. PMID: 32546652 Free PMC article.

10

Clinical development success rates and social value of pediatric Phase 1 trials in oncology.

Wasylewski MT, Strzebonska K, Koperny M, Polak M, Kimmelman J, Waligora M. Wasylewski MT, et al. Among authors: kimmelman j. PLoS One. 2020 Jun 24;15(6):e0234911. doi: 10.1371/journal.pone.0234911. eCollection 2020. PLoS One. 2020. PMID: 32579564 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

197 results

Search Page